MultiRBE: Treatment planning for protons with selective radiobiological effectiveness
Related Experiment Video
Updated: Jan 22, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Daniel Sánchez-Parcerisa1,2, Miguel López-Aguirre1,2, Ana Dolcet Llerena3
1Grupo de Física Nuclear & IPARCOS, Departamento de Estructura de la Materia, Física Térmica y Electrónica, CEI Moncloa, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Purpose:
Clinical treatment planning protocols for protons recommend a uniform value radiobiological effectiveness (RBE) of protons of 1.1 throughout the treatment field, despite evidence from in-vitro and animal studies that proton RBE increases with linear energy transfer (LET), causing tissues placed distally to the target location to receive a presumably higher biological dose than estimated. While several voices in the medical physics community have advocated for variable RBE-based optimization, the uncertainties in RBE models have prevented its implementation in clinical practice, since an overestimation of RBE could cause significant target underdosage.
Methods:
We propose a mixed RBE model (MultiRBE), where a uniform RBE is used in the target contours to ensure an adequate tumor coverage in terms of physical dose, but a variable RBE is used elsewhere. Our model was implemented in the open-source treatment planning system matRad and three example cases were planned: a homogeneous phantom, a prostate tumor and a head-and-neck case. MultiRBE was used for plan optimization, and the produced plans were subsequently evaluated in terms of physical dose coverage (V95% ) and variable RBE-weighted dose in organs at risk and normal tissue complication probabilities (NTCP), where prediction models were available.
Results:
The planning algorithm showed potential for reducing the biological dose in organs surrounding the planning target and thus decreasing the probability for complications in normal tissue (by up to 62% in the prostate case and 37% in the head-and-neck patient). This was achieved without compromising the target coverage or homogeneity in terms of physical dose, as a result of a smarter redistribution of dose among the surrounding tissues with regard to the optimization constraints.
Conclusions:
The results prove the ability of the MultiRBE model to reduce biological dose at healthy tissues without compromising the dose coverage of the tumor, with independence of the variable RBE models used.
Related Concept Videos
Sampling Plans
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
Planning Nursing Care I
Planning Nursing Care II
Proton (¹H) NMR: Chemical Shift
Absorption signals of all the protium nuclei...
What is Natural Selection?
¹H NMR of Labile Protons: Temporal Resolution
The –OH proton in alcohols typically appears in the range of δ 2 to 5 ppm but can vary depending on the specific...

